When a stock screen filters for strong earnings and revenue growth while simultaneously flagging a technical breakout setup, the resulting candidate represents an intersection of fundamental momentum and market timing. REPLIGEN CORP (NASDAQ:RGEN) is a current example that matches this combined methodology, showing meaningful expansion in its top and bottom lines while its price structure consolidates near resistance.
Why Repligen qualifies as a strong-growth stock
The fundamental profile of Repligen demonstrates the kind of compounding that growth investors seek. The company earns a ChartMill Growth Rating of 7 out of 10, supported by several concrete trends:
- Revenue grew 16.49% over the last year, with a five-year average of 15.05%
- Earnings per share increased 20.86% in the same period
- Future EPS is expected to accelerate to 24.41% annual growth
- Operating margins and profit margins both rank above 67% of industry peers
These figures point to a business that is not merely growing but doing so with pricing power and operating leverage. A key risk is the elevated valuation: the trailing P/E of 71.69 reflects that the market has already priced in much of the expected growth. However, the acceleration in EPS growth from a 0.60% historical average to double???digit forward estimates suggests the re???rating may be sustainable. Investors who want the full breakdown of Repligen’s fundamental picture can consult the detailed fundamental analysis report.
Technical setup and breakout potential
On the technical side, Repligen scores a 7 out of 10 overall, with a Setup Rating of 7. The chart shows a price that has consolidated between roughly 129 and 154 over the past month, sitting near the middle of that range. Key technical observations include:
- A resistance zone from 146.92 to 148.56, formed by multiple trend lines
- A support zone from 131.05 to 132.24, backed by moving averages in daily and weekly time frames
- Rising short???term moving averages (SMA20 at 141.70, SMA50 at 132.24), indicating the consolidation is tilting bullish
- Recent pick???up in volume, often a signal that larger players are positioning
If Repligen breaks above the 148.57 resistance level, the measured move could target the next resistance near 166.21. The setup suggests a buy stop just above that zone with a stop loss below support. For a full technical walkthrough, see the technical analysis report.
Why the combination matters
Growth stocks that lack a constructive chart structure often suffer from poor entry timing. Repligen avoids that pitfall: it has decent health (Health Rating 7) and average profitability (Profitability Rating 6), meaning the growth is not built on a fragile balance sheet. The Altman???Z score of 6.70 and a current ratio of 9.05 confirm it can fund its own expansion without excessive leverage. When a company with accelerating earnings enters a low???volatility consolidation near a clear resistance level, the risk???reward profile becomes more favorable than chasing a stock that has already run.
Investors looking for more stocks that pass this same combination of strong growth and technical breakout patterns can explore the current list via this dedicated screen.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup
When a stock screen filters for strong earnings and revenue growth while simultaneously flagging a technical breakout setup, the resulting candidate represents an intersection of fundamental momentum and market timing. REPLIGEN CORP (NASDAQ:RGEN) is a current example that matches this combined methodology, showing meaningful expansion in its top and bottom lines while its price structure consolidates near resistance.
Why Repligen qualifies as a strong-growth stock
The fundamental profile of Repligen demonstrates the kind of compounding that growth investors seek. The company earns a ChartMill Growth Rating of 7 out of 10, supported by several concrete trends:
These figures point to a business that is not merely growing but doing so with pricing power and operating leverage. A key risk is the elevated valuation: the trailing P/E of 71.69 reflects that the market has already priced in much of the expected growth. However, the acceleration in EPS growth from a 0.60% historical average to double???digit forward estimates suggests the re???rating may be sustainable. Investors who want the full breakdown of Repligen’s fundamental picture can consult the detailed fundamental analysis report.
Technical setup and breakout potential
On the technical side, Repligen scores a 7 out of 10 overall, with a Setup Rating of 7. The chart shows a price that has consolidated between roughly 129 and 154 over the past month, sitting near the middle of that range. Key technical observations include:
If Repligen breaks above the 148.57 resistance level, the measured move could target the next resistance near 166.21. The setup suggests a buy stop just above that zone with a stop loss below support. For a full technical walkthrough, see the technical analysis report.
Why the combination matters
Growth stocks that lack a constructive chart structure often suffer from poor entry timing. Repligen avoids that pitfall: it has decent health (Health Rating 7) and average profitability (Profitability Rating 6), meaning the growth is not built on a fragile balance sheet. The Altman???Z score of 6.70 and a current ratio of 9.05 confirm it can fund its own expansion without excessive leverage. When a company with accelerating earnings enters a low???volatility consolidation near a clear resistance level, the risk???reward profile becomes more favorable than chasing a stock that has already run.
Investors looking for more stocks that pass this same combination of strong growth and technical breakout patterns can explore the current list via this dedicated screen.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »